Condensed Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets:
Cash and cash equivalents	$ 3,880,290	$ 12,621,477
Trade receivables	95,014	100,164
Related party receivables and deposits	10,225	596,339
Inventories	2,097,498	2,159,553
Prepaid expenses and other current assets	759,705	235,305
Total current assets	6,842,732	15,712,838
Property, Plant and Equipment:	39,591,677	39,979,013
Less accumulated depreciation and amortization	(16,471,789)	(12,725,298)
Net property, plant and equipment	23,119,888	27,253,715
Other Assets:
Patents, net of amortization of $74,077 and $48,150, respectively	834,654	500,879
Other non-current assets	53,750	56,563
Total Other Assets	888,404	557,442
Total Assets	30,851,024	43,523,995
Current Liabilities:
Accounts payable	607,571	855,373
Accrued expenses	1,686,565	1,788,635
Current portion of long-term debt	278,342	264,935
Make-whole dividend liability	1,652,745	0
Total current liabilities	4,225,223	2,908,943
Long-Term Debt	6,139,671	6,350,135
Accrued Warranty Liability	47,937	38,187
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $0.0001 par value, 25,000,000 shares authorized; 712,390 and 0 shares issued and outstanding, respectively ($5,765,206 Liquidation Preference)	71	0
Common stock, $0.0001 par value, 125,000,000 shares authorized; 54,789,971 and 51,143,906 shares issued and outstanding, respectively	5,479	5,114
Additional paid in capital	256,458,392	245,996,950
Deficit accumulated during the development stage	(236,025,749)	(211,775,334)
Total stockholders' equity	20,438,193	34,226,730
Total Liabilities and Stockholders' Equity	$ 30,851,024	$ 43,523,995